Vaccine Hesitancy
52
2
4
33
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.7%
4 terminated out of 52 trials
89.2%
+2.6% vs benchmark
0%
0 trials in Phase 3/4
24%
8 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (52)
Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana
Predicting Vaccine Hesitancy Using Machine Learning
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
Parents' Knowledge and Attitudes Towards Vaccinating Their Children
Communication Strategies to Increase HPV Vaccination Intention
Effect of Primary Care Education on Parents' Health-Related Perceptions and Attitudes
Increasing Vaccine Uptake Among Adolescents in the Rural South
Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
Motivational Interviewing for Vaccine Uptake in Latinx Adults
Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
Impact of Supportive Vaccine Communication on Vaccine Desicion Processes
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Thimble Mindfulness App and Recovery Patch Descriptions
Culturally and Linguistically Appropriate Vaccine Education
The Impact of a Web-based Psychoeducation Programme with a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy
Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
Dengue Vaccine Hesitancy Among International Travelers